Original article
General thoracic
Preoperative Maximum Oxygen Consumption Is Associated With Prognosis After Pulmonary Resection in Stage I Non-Small Cell Lung Cancer

Presented at the Poster Session of the Fiftieth Annual Meeting of The Society of Thoracic Surgeons, Orlando, FL, Jan 25–29, 2014.
https://doi.org/10.1016/j.athoracsur.2014.04.029Get rights and content

Background

The objective of this investigation was to evaluate whether maximum oxygen consumption (VO2max) is a reliable prognostic factor after lung resection for pathologic stage I non-small cell lung cancer (NSCLC).

Methods

Observational analysis of 157 patients undergoing pulmonary lobectomy or segmentectomy for pathologic stage I (T1 or T2-N0 only) NSCLC, with preoperative measurement of Vo2max and complete follow-up (2006–2011). Survival was calculated by the Kaplan-Meier method. The log-rank test was used to assess differences in survival between groups. The relationships between survival and several baseline and clinical variables were determined by Cox multivariate analyses.

Results

The median follow-up time was 40 months. The average preoperative Vo2max was 16.1 mL/kg · min and 69% of predicted value. Sixty-two (40%) patients had a Vo2max below 60%. The median and 5-year overall survivals of patients with preoperative Vo2max above 60% were significantly longer than in those with Vo2max below 60% (median not reached vs 48 months: 73% vs 40%, p = 0.0004). Cox regression model showed that an age older than 70 years (p = 0.005, hazard ratio 2.3) and Vo2max below 60% (p = 0.001, hazard ratio 2.4) were independent prognostic factors significantly associated with overall survival. Cancer-specific survival was also longer in patients with Vo2max above 60% (81% vs 61%, p = 0.01).

Conclusions

Exercise tolerance may influence the physiologic outcomes associated with cancer that can potentially affect survival. Physical rehabilitation aimed at improving exercise tolerance can possibly improve the long-term prognosis after operations for lung cancer.

Section snippets

Patients and Methods

This was a single-center observational analysis performed on a prospective database. The local institutional review board approved the study, and all patients gave their informed consent to participate in the institutional prospective database and have their data used for research and clinical purposes.

All patients undergoing pulmonary lobectomy or segmentectomy for pathologic stage I (pT1 or pT2-N0 only) NSCLC and who performed a preoperative cardiopulmonary exercise test as part of their

Results

Table 1 summarizes the patients' characteristics. During the same period, 140 patients with early-stage NSLC did not perform CPET because they did not meet the criteria or were unable to perform the test because of physical or mental limitations. They had similar 5-year survival rates compared with those who performed the exercise test (60% vs 65%, p = 0.2). The median follow-up time was 40 months. The average preoperative Vo2max was 16.1 mL/kg · min or 69% of predicted value. Testing for a

Background and Rationale

A growing body of literature is showing an association between better physical fitness and long-term survival in lung cancer patients.

In other types of cancers, improving fitness through regular exercise has been shown to be associated with a 30% to 50% reduction in risk of cancer-specific mortality and all-cause mortality 9, 10, 11, 12.

In lung cancer patients, some authors have found that impaired physical condition at preoperative exercise testing 5, 6, 13 and the patient's perception of

References (27)

  • L. Kohman et al.

    CALGB 140803-Association between cardiorespiratory fitness and overall survival in operable lung cancer patients: ancillary analysis of protocol 9238

    J Clin Oncol

    (2009)
  • R.J. Cerfolio et al.

    A nondivided intercostal muscle flap further reduces pain of thoracotomy: a prospective randomized trial

    Ann Thorac Surg

    (2008)
  • Cited by (46)

    • Validity of Estimated Cardiorespiratory Fitness in Patients With Primary Breast Cancer

      2022, JACC: CardioOncology
      Citation Excerpt :

      Poor Vo2peak is prevalent across the breast cancer continuum (ie, from diagnosis to survivorship)10,29,30 and correlates with heightened symptom burden.31 Vo2peak is also a significant predictor of all-cause10,32 and cause-specific mortality,33 even after adjustment for important clinical covariates. Despite the importance of accurate assessment of Vo2peak in the large and rapidly growing population of patients with cancer,34 prediction equations are commonly used in oncology clinical and research settings.13

    View all citing articles on Scopus
    View full text